Huaren Pharmaceutical Co., Ltd. 300110.SZ Stock
Huaren Pharmaceutical Co., Ltd. Price Chart
Huaren Pharmaceutical Co., Ltd. 300110.SZ Financial and Trading Overview
| Huaren Pharmaceutical Co., Ltd. stock price | 3.49 CNY |
| Previous Close | 4.04 CNY |
| Open | 4.05 CNY |
| Bid | 4.06 CNY x 0 |
| Ask | 4.07 CNY x 0 |
| Day's Range | 4.04 - 4.08 CNY |
| 52 Week Range | 3.59 - 6.03 CNY |
| Volume | 8.48M CNY |
| Avg. Volume | 13.42M CNY |
| Market Cap | 4.81B CNY |
| Beta (5Y Monthly) | 0.513356 |
| PE Ratio (TTM) | 23.941177 |
| EPS (TTM) | 0.16 CNY |
| Forward Dividend & Yield | 0.02 (0.44%) |
| Ex-Dividend Date | June 17, 2022 |
| 1y Target Est | N/A |
300110.SZ Valuation Measures
| Enterprise Value | 6.14B CNY |
| Trailing P/E | 23.941177 |
| Forward P/E | 81.4 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.938831 |
| Price/Book (mrq) | 1.8704044 |
| Enterprise Value/Revenue | 3.748 |
| Enterprise Value/EBITDA | 15.827 |
Trading Information
Huaren Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.513356 |
| 52-Week Change | 10.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.03 CNY |
| 52 Week Low | 3.59 CNY |
| 50-Day Moving Average | 4.18 CNY |
| 200-Day Moving Average | 4.31 CNY |
300110.SZ Share Statistics
| Avg. Volume (3 month) | 13.42M CNY |
| Avg. Daily Volume (10-Days) | 11.23M CNY |
| Shares Outstanding | 1.18B |
| Float | 753.7M |
| Short Ratio | N/A |
| % Held by Insiders | 44.82% |
| % Held by Institutions | 0.45% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.021 |
| Trailing Annual Dividend Yield | 0.51% |
| 5 Year Average Dividend Yield | 41.00% |
| Payout Ratio | 0.108 |
| Last Split Factor | 15:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 12.02% |
| Operating Margin (ttm) | 14.49% |
| Gross Margin | 40.78% |
| EBITDA Margin | 23.67% |
Management Effectiveness
| Return on Assets (ttm) | 2.82% |
| Return on Equity (ttm) | 7.70% |
Income Statement
| Revenue (ttm) | 1.64B CNY |
| Revenue Per Share (ttm) | 1.39 CNY |
| Quarterly Revenue Growth (yoy) | 4.59% |
| Gross Profit (ttm) | 689.19M CNY |
| EBITDA | 387.7M CNY |
| Net Income Avi to Common (ttm) | 196.88M CNY |
| Diluted EPS (ttm) | 0.17 |
| Quarterly Earnings Growth (yoy) | 64.20% |
Balance Sheet
| Total Cash (mrq) | 226.47M CNY |
| Total Cash Per Share (mrq) | 0.19 CNY |
| Total Debt (mrq) | 1.52B CNY |
| Total Debt/Equity (mrq) | 57.43 CNY |
| Current Ratio (mrq) | 1.516 |
| Book Value Per Share (mrq) | 2.176 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 280.68M CNY |
| Levered Free Cash Flow (ttm) | 287.46M CNY |
Profile of Huaren Pharmaceutical Co., Ltd.
| Country | China |
| State | N/A |
| City | Qingdao |
| Address | High-tech Industrial Park |
| ZIP | 266101 |
| Phone | 86 532 8870 1000 |
| Website | https://www.qdhuaren.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 2264 |
Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. The company offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. It also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and carbohydrate metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine solution protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, the company offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. Huaren Pharmaceutical Co., Ltd. was founded in 1998 and is based in Qingdao, China.
Q&A For Huaren Pharmaceutical Co., Ltd. Stock
What is a current 300110.SZ stock price?
Huaren Pharmaceutical Co., Ltd. 300110.SZ stock price today per share is 3.49 CNY.
How to purchase Huaren Pharmaceutical Co., Ltd. stock?
You can buy 300110.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Huaren Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Huaren Pharmaceutical Co., Ltd. is 300110.SZ.
Which industry does the Huaren Pharmaceutical Co., Ltd. company belong to?
The Huaren Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Huaren Pharmaceutical Co., Ltd. have in circulation?
The max supply of Huaren Pharmaceutical Co., Ltd. shares is 1.18B.
What is Huaren Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Huaren Pharmaceutical Co., Ltd. PE Ratio is 21.81250000 now.
What was Huaren Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Huaren Pharmaceutical Co., Ltd. EPS is 0.16 CNY over the trailing 12 months.
Which sector does the Huaren Pharmaceutical Co., Ltd. company belong to?
The Huaren Pharmaceutical Co., Ltd. sector is Healthcare.